Xenon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $7,500 |
Gross Profit | -611 | -77,054 | -632 | 7,500 |
EBITDA | -104,112 | -89,578 | -93,597 | -72,079 |
EBIT | -104,723 | -90,219 | -94,229 | -72,738 |
Net Income | -105,261 | -90,896 | -84,706 | -65,047 |
Net Change In Cash | 0 | 0 | 0 | 7,500 |
Free Cash Flow | -81,799 | -72,033 | -64,390 | -61,695 |
Cash | 199,163 | 104,514 | 135,381 | 116,657 |
Basic Shares | 79,253 | 79,247 | 78,953 | 78,687 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,500 | $0 | $0 | $9,434 |
Gross Profit | 4,957 | -2,560 | -167,512 | 9,434 |
EBITDA | -342,351 | -235,859 | -210,513 | -127,519 |
EBIT | -344,894 | -238,419 | -214,054 | -129,143 |
Net Income | -345,910 | -234,330 | -182,393 | -125,373 |
Net Change In Cash | 7,500 | 0 | 0 | 9,434 |
Cost of Revenue | -115,962 | |||
Free Cash Flow | -279,917 | -184,464 | -150,944 | -101,324 |
Cash | 199,163 | 142,712 | 148,643 | 57,242 |
Basic Shares | 79,253 | 77,894 | 66,889 | 60,542 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$1.31 |
2025-09-30 | -$1.15 |
2025-06-30 | -$1.07 |
